TABLE 6.
Evaluation of web‐based tools for biopsy samples of OTSCC.
| Web‐based tools | Positive (%) | Negative (%) | Total | Area under ROC curve (95% CI) | p‐value | Number and sensitivity (%) | Number and specificity (%) | Accuracy (%) |
|---|---|---|---|---|---|---|---|---|
| Prediction of locoregional recurrence‐free survival | ||||||||
| (B) Recurrence‐free survival (Net benefit) a | 19 (73.07) | 7 (26.93) | 26 | 0.594 (0.30–0.88) | 0.470 | 2 (10.5) | 5 (71.4) | 26 |
| (B) Recurrence‐free survival (Surgery alone) a | 20 (74.07) | 7 (25.93) | 27 | 0.632 (0.38–0.88) | 0.306 | 13 (65) | 4 (57.1) | 62 |
| (B) Recurrence‐free survival (Surgery + RT) a | 17 (80.95) | 4 (19.05) | 21 | 0.713 (0.40–1.00) | 0.194 | 14 (66.7) | 5 (83.3) | 70 |
| Prediction of survival | ||||||||
| (B) 5‐year survival | 14 (42.42) | 19 (57.58) | 33 | 0.581 (0.37–0.78) | 0.434 | 8 (57.1) | 9 (47.4) | 51 |
| (C) Years mean survival | 14 (42.42) | 19 (57.58) | 33 | 0.639 (0.44–0.83) | 0.178 | 11 (78.6) | 9 (47.4) | 60 |
| (D) 5‐year survival rate | 14 (42.42) | 19 (57.58) | 33 | 0.656 (0.47–0.86) | 0.094 | 10 (71.4) | 12 (63.2) | 66 |
| (D) 10‐year survival rate | 14 (42.42) | 19 (57.58) | 33 | 0.639 (0.43–0.84) | 0.249 | 11 (78.6) | 11 (57.9) | 66 |
Abbreviation: RT, Radiotherapy.
a
Cases with missing data.